Proscillaridin: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
| Verifiedfields = changed |
| Verifiedfields = changed |
||
| verifiedrevid = 464375437 |
| verifiedrevid = 464375437 |
||
| IUPAC_name = 5-[(3''S'',8''R'',9''S'',10''R'',13''R'',14''S'',17''R'')- |
| IUPAC_name = 5-[(3''S'',8''R'',9''S'',10''R'',13''R'',14''S'',17''R'')-14-Hydroxy- 10,13-dimethyl-3-((2''R'',3''R'',4''R'',5''R'',6''R'')-3,4,5-trihydroxy- 6-methyltetrahydro-2''H''-pyran-2-yloxy)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro- 1''H''-cyclopenta[''a'']phenanthren-17-yl]-2''H''-pyran-2-one |
||
| image = Proscillaridin structure.svg |
| image = Proscillaridin structure.svg |
||
Line 30: | Line 30: | ||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = KC6BL281EN |
| UNII = KC6BL281EN |
||
| synonyms = 3β-Rhamnosido-14β-hydroxybufa-4,20,22-trienolide |
|||
<!--Chemical data--> |
<!--Chemical data--> |
Revision as of 16:43, 23 November 2016
![]() | |
Clinical data | |
---|---|
Other names | 3β-Rhamnosido-14β-hydroxybufa-4,20,22-trienolide |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.702 |
Chemical and physical data | |
Formula | C30H42O8 |
Molar mass | 530.650 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Proscillaridin is a cardiac glycoside, a kind of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). It is of the bufanolide type and can be obtained from plants of the genus Scilla and in Drimia maritima (Scilla maritima).[1]
The aglycone of proscillaridin is scillarenin.
References